Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$349,932,860
-$53,266,631 QoQ
Shares Held
2,076,260
-32.2% QoQ
Ownership
2.04%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#10
of 768 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $775,744,366 across 48 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (45.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
2,076,260 | $349,932,860 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
6,775,349 | $67,753,490 | |
| 3 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,184,378 | $55,085,420 | |
| 4 | ALKS |
Alkermes plc.
|
1,038,311 | $54,407,496 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
561,480 | $35,906,646 | |
| 6 | ZTS |
Zoetis Inc.
|
386,428 | $27,768,716 | |
| 7 | LQDA |
Liquidia Corp
|
266,829 | $21,274,276 | |
| 8 | IRWD |
Ironwood Pharmaceuticals Inc
|
4,556,089 | $19,181,134 |
All Filings in NBIX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $349,932,860 | 2,076,260 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $403,199,491 | 3,060,570 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $139,675,744 | 984,811 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $48,791,174 | 347,565 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $1,128,341 | 10,202 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,654,241 | 26,771 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $10,373,026 | 90,028 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $18,624,272 | 135,282 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $21,761,017 | 157,780 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $29,633,746 | 224,907 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,670,900 | 50,408 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $22,423,219 | 237,786 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $37,459,295 | 370,078 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $68,202,748 | 571,021 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $39,172,372 | 368,820 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,306,864 | 23,665 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $34,365,281 | 366,563 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $14,233,184 | 167,115 | Shares | Sole | 2022-02-14 | |
| 2020-06-30 | $16,957,024 | 138,992 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $26,988,713 | 311,828 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||